Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franklin Fuda

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Cytometry. Part B, Clinical Cytometry|October 11, 2014
Acute Megakaryoblastic Leukemia Associated with Trisomy 21 Demonstrates a Distinct ImmunophenotypeLinlin Wang, John M Peters, Franklin Fuda, et al.
Cytometry. Part B, Clinical Cytometry|November 1, 2014
Acute megakaryoblastic leukemia associated with trisomy 21 demonstrates a distinct immunophenotypeLinlin Wang, John M Peters, Franklin Fuda, et al.
Genes, Chromosomes & Cancer|June 12, 2026
Cytogenetic and Molecular Analysis of a "Double-Hit" RUNX1 Including a RUNX1 p.Trp279* and a Cryptic Novel t(6;21)(q25;q22)/RUNX1::ARID1B in Acute Myeloid LeukemiaRolando García, Jing Xu, Lan Yu, et al.
International Journal of Laboratory Hematology|November 3, 2022
Adult mixed phenotype acute leukemia (MPAL): B/myeloid MPAL<sup>isoMPO</sup> is distinct from other MPAL subtypesOlga K Weinberg, Jake Dennis, Hamid Zia, et al.
Cytometry. Part B, Clinical Cytometry|February 9, 2019
Bright CD38 Expression by Flow Cytometric Analysis Is a Biomarker for Double/Triple Hit Lymphomas with a Moderate Sensitivity and High SpecificityAbdullah Alsuwaidan, Elaina Pirruccello, Jesse Jaso, et al.
Journal of Pediatric Hematology/Oncology|September 14, 2020
Mixed Phenotype Acute Leukemia, B/Myeloid (Bilineal and Biphenotypic), With t(2;22)(q35;q12);EWSR1-FEVCrystal Montgomery-Goecker, Prasad Koduru, Giovanni Botten, et al.
Human Pathology|April 11, 2025
Investigation of NPM1 mutation frequency in cutaneous blastic plasmacytoid dendritic cell neoplasmsHanan Hamdan, Alexa Siddon, Maximiliano Ramia de Cap, et al.
Cytometry. Part B, Clinical Cytometry|September 14, 2022
Genomic profile of TdT<sup>positive</sup> MYC/BCL2 rearranged high-grade B-cell lymphoma supporting its diagnosis as mature aggressive lymphomaHanan Hamdan, Ly Luu, Madeleine Opsahl, et al.
Pediatric Blood & Cancer|January 4, 2025
Genomic and Clinicopathological Characterization of CRLF2-Rearranged Mixed Phenotype Acute LeukemiaLina Han, Ruifang Zheng, Franklin Fuda, et al.
Leukemia Research|May 2, 2021
MYC protein expression does not correlate with MYC abnormalities detected by FISH but predicts an unfavorable prognosis in de novo acute myeloid leukemiaPu Chen, Lucas Redd, Yao Schmidt, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Cytometry. Part B, Clinical Cytometry|October 11, 2014
Acute Megakaryoblastic Leukemia Associated with Trisomy 21 Demonstrates a Distinct ImmunophenotypeLinlin Wang, John M Peters, Franklin Fuda, et al.
Cytometry. Part B, Clinical Cytometry|November 1, 2014
Acute megakaryoblastic leukemia associated with trisomy 21 demonstrates a distinct immunophenotypeLinlin Wang, John M Peters, Franklin Fuda, et al.
Genes, Chromosomes & Cancer|June 12, 2026
Cytogenetic and Molecular Analysis of a "Double-Hit" RUNX1 Including a RUNX1 p.Trp279* and a Cryptic Novel t(6;21)(q25;q22)/RUNX1::ARID1B in Acute Myeloid LeukemiaRolando García, Jing Xu, Lan Yu, et al.
International Journal of Laboratory Hematology|November 3, 2022
Adult mixed phenotype acute leukemia (MPAL): B/myeloid MPAL<sup>isoMPO</sup> is distinct from other MPAL subtypesOlga K Weinberg, Jake Dennis, Hamid Zia, et al.
Cytometry. Part B, Clinical Cytometry|February 9, 2019
Bright CD38 Expression by Flow Cytometric Analysis Is a Biomarker for Double/Triple Hit Lymphomas with a Moderate Sensitivity and High SpecificityAbdullah Alsuwaidan, Elaina Pirruccello, Jesse Jaso, et al.
Journal of Pediatric Hematology/Oncology|September 14, 2020
Mixed Phenotype Acute Leukemia, B/Myeloid (Bilineal and Biphenotypic), With t(2;22)(q35;q12);EWSR1-FEVCrystal Montgomery-Goecker, Prasad Koduru, Giovanni Botten, et al.
Human Pathology|April 11, 2025
Investigation of NPM1 mutation frequency in cutaneous blastic plasmacytoid dendritic cell neoplasmsHanan Hamdan, Alexa Siddon, Maximiliano Ramia de Cap, et al.
Cytometry. Part B, Clinical Cytometry|September 14, 2022
Genomic profile of TdT<sup>positive</sup> MYC/BCL2 rearranged high-grade B-cell lymphoma supporting its diagnosis as mature aggressive lymphomaHanan Hamdan, Ly Luu, Madeleine Opsahl, et al.
Pediatric Blood & Cancer|January 4, 2025
Genomic and Clinicopathological Characterization of CRLF2-Rearranged Mixed Phenotype Acute LeukemiaLina Han, Ruifang Zheng, Franklin Fuda, et al.
Leukemia Research|May 2, 2021
MYC protein expression does not correlate with MYC abnormalities detected by FISH but predicts an unfavorable prognosis in de novo acute myeloid leukemiaPu Chen, Lucas Redd, Yao Schmidt, et al.
Pageof 6